ALLMedicine™ Digital Rectal Examination Center

Jan 20th, 2021 - The watch-and-wait strategy offers a non-invasive therapeutic alternative for rectal cancer patients who have achieved a clinical complete response (cCR) after chemoradiotherapy. This study aimed to investigate the long-term clinical outcomes of t...

Jan 17th, 2021 - Diagnosis of prostate cancer (CaP) is based on digital rectal examination (DRE) and/or elevated prostate specific antigen (PSA) level. This approach lacks sensitivity and specificity and is associated with many negative biopsies, high rate of diag...

Jan 10th, 2021 - This study aimed to develop and validate a predictive model for the assessment of clinically significant prostate cancer (csPCa) in men, prior to prostate biopsies, based on bi-parametric magnetic resonance imaging (bpMRI) and clinical parameters....

Dec 29th, 2020 - Malignant lymphomas of the prostate are very rare tumours and are generally not considered in the clinical or pathological diagnosis of prostatic enlargement. We report a case of a 56-year-old man who presented with long-standing history of low ba...

Dec 1st, 2020 - Heterogeneity of prostate cancer (PCa) contributes to inaccurate cancer screening and diagnosis, unnecessary biopsies, and overtreatment. We intended to develop non-invasive urine tests for accurate PCa diagnosis to avoid unnecessary biopsies. Usi...

May 19th, 2019 - To develop a risk classifier using urine‐derived extracellular vesicle (EV)‐RNA capable of providing diagnostic information on disease status prior to biopsy, and prognostic information for men on active surveillance (AS). Patients and Methods Po...

Feb 28th, 2018 - Although the digital rectal examination (DRE) is commonly performed to screen for prostate cancer, there is limited data to support its use in primary care. This review and meta-analysis aims to evaluate the diagnostic accuracy of DRE in screening...

Dec 31st, 2017 - This guideline addresses prostate cancer early detection for the purpose of reducing prostate cancer mortality with the intended user as the urologist. This document does not make a distinction between early detection and screening for prostate ca.

May 5th, 2017 - Despite the frequent statement that "most men die with prostate cancer, not of it," the reality is that prostate cancer is second only to lung cancer as a cause of death from malignancy in American men. The primary goal during baseline evaluation ...

Aug 19th, 2012 - An American Society of Clinical Oncology (ASCO) provisional clinical opinion (PCO) offers timely clinical direction to the ASCO membership after publication or presentation of potentially practice-changing data from major studies. This PCO address.

Jan 20th, 2021 - The watch-and-wait strategy offers a non-invasive therapeutic alternative for rectal cancer patients who have achieved a clinical complete response (cCR) after chemoradiotherapy. This study aimed to investigate the long-term clinical outcomes of t...

Jan 17th, 2021 - Diagnosis of prostate cancer (CaP) is based on digital rectal examination (DRE) and/or elevated prostate specific antigen (PSA) level. This approach lacks sensitivity and specificity and is associated with many negative biopsies, high rate of diag...

Jan 10th, 2021 - This study aimed to develop and validate a predictive model for the assessment of clinically significant prostate cancer (csPCa) in men, prior to prostate biopsies, based on bi-parametric magnetic resonance imaging (bpMRI) and clinical parameters....

Dec 29th, 2020 - Malignant lymphomas of the prostate are very rare tumours and are generally not considered in the clinical or pathological diagnosis of prostatic enlargement. We report a case of a 56-year-old man who presented with long-standing history of low ba...

Dec 1st, 2020 - Heterogeneity of prostate cancer (PCa) contributes to inaccurate cancer screening and diagnosis, unnecessary biopsies, and overtreatment. We intended to develop non-invasive urine tests for accurate PCa diagnosis to avoid unnecessary biopsies. Usi...

Dec 4th, 2019 - Levels of potential biomarkers for prostate cancer in urine were comparable after a digital rectal examination (DRE) in a physician's office and at a man's home, suggesting the feasibility of an at-home test, say UK researchers in a small prelimin...

Sep 22nd, 2019 - A digital rectal examination (DRE) affords access to several key structures and enables an observant clinician to identify several disease processes pertaining to the rectum, anus, prostate, seminal vesicles, bladder, and perineum. In females, it ...

Sep 22nd, 2019 - A digital rectal examination (DRE) affords access to several key structures and enables an observant clinician to identify several disease processes pertaining to the rectum, anus, prostate, seminal vesicles, bladder, and perineum. In females, it ...

Sep 22nd, 2019 - A digital rectal examination (DRE) affords access to several key structures and enables an observant clinician to identify several disease processes pertaining to the rectum, anus, prostate, seminal vesicles, bladder, and perineum. In females, it ...

May 19th, 2019 - To develop a risk classifier using urine‐derived extracellular vesicle (EV)‐RNA capable of providing diagnostic information on disease status prior to biopsy, and prognostic information for men on active surveillance (AS). Patients and Methods Po...